THE FREQUENCY AND SEVERITY OF EXTRASKELETAL MANIFESTATIONS OF ANKYLOSING SPONDYLITIS

Ankylosing spondylitis (AS) is a systemic inflammatory disease involving not only the skeleton, but also other organs. The data on the frequency and clinical significance of extraskeletal manifestations are contradictory. Objective: to assess the frequency and severity of extraskeletal manifestations (ESMs) of AS in the authors' own clinical practice. Subjects and methods. 452 patients (363 men and 89 women) with AS fulfilling the 1984 relevant New York criteria were examined at the V.A. Nasonova Research Institute of Rheumatology in 2005 and 2014. The patients' median age was 31.5 [24; 41] years; median disease onset age, 19 [15; 23] years; disease duration, 11 [7; 18] years; HLA B27 was identified in 442 (97.7%) patients. In addition to standard laboratory and instrumental examinations, transthoracic echocardiography was performed in 172 patients. Rehberg's test, IgA test, histological examination of subcutaneous fat tissue or duodenal mucosa for amyloid, and renal ultrasound were made if there were urinary abnormalities and elevated creatinine levels. If indicated, there were consultations by an ophthalmologist with an appropriate instrumental examination (with evidence of uveitis in the history), a dermatologist, a nephrologist, an urologist, a gastroenterologist, and a endoscopist. Uveitis, cardiac involvement (conduction disturbance, aortic and valvular changes), inflammatory bowel disease (IBD), glomerulonephritis, and psoriasis were borne in mind as ESMs. The absolute number and percentage of patients having any ESM over the follow-up period were estimated. The number of exacerbations per year and that of complications were taken into account when evaluating uveitis; the magnitude of valvular regurgitation and the presence of prosthetic valves and a pacemaker were considered when assessing cardiac damage; the total body surface area (BSA) and the psoriasis areas and severity index (PASI) were estimated in psoriasis; the presence and stage of chronic kidney disease (CKD) and/or macrohematuria were kept in mind in nephropathy; when evaluating IBD, the Harvey–Bradshaw index (HBI) was determined on the basis of a stool frequency, the presence of blood in the stool, abdominal pain, and general well-being. Results and discussion. ESMs were detected in 218 (48%) of the 452 patients. Uveitis was present in 140 (30%) patients; in one-fourth of them, it relapsed frequently: three or more exacerbations per year and more than 10 during the disease; 41 (29%) patients had uveitis complications accompanied by visual impairment. Cardiac conduction disturbance was revealed in 61 (13%) patients. Five of them underwent pacemaker implantation. 71 (41.2%) patients were found to have aortic and valvular changes, including aortic root dilatation/thickening in 60 (34.8%) patients and aortic/mitral valve leaflet thickening in 63 (36.6%). Grades 3 and 4 valvular regurgitation was noted in 10 (5.8%) patients; valve replacement was carried out in 9 (5.2%) cases. Nephritis was diagnosed in 16 (3.5%) patients, 4 of them had Stage 2 or above of CKD. Psoriasis was present in 17 (3.7%) patients; 2 of them had severe psoriasis (BSA >10%). IBD (ulcerative colitis or Crohn's disease) was diagnosed in 16 (3.5%) patients, including 4 who showed a severe course. 79 (36%) patients were observed to have a concurrence of two or more ESMs; that of uveitis and heart disease was most commonly seen. Conclusion. ESMs are observed in nearly half (48%) of the patients with AS and can be concurrent; the most common ESMs of AS are uveitis, aortic root and heart valve lesions, and cardiac conduction disturbance. ESMs worsen the course and prognosis of AS.

1. Wright V. A unifying concept of the seronegative polyarthritis. Clin Orthop. 1979 Sep;143:814.

2. Wright V, Moll MH. Seronegative polyarthritis. Amsterdam, New York: North Holland Press; 1976. 488 p.

3. Wright V. Relationship between ankylosing spondylitis and other spondarthritides. In: Moll JMH. Ankylosing Spondylitis. Edinburgh, London, Melbourne, New York: Churchill Livingstone; 1980. P. 42-51.

4. Khan M, van der Linden S. A wider spectrum of spondyloarthropatyes. Semin Arthr Rheum. 1990 Oct; 20(2):107-13. doi: 10.1016/0049-0172(90)90023-9

5. Cruyssen B, Ribbens C, Boonen A, et al. The epidemiology of ankylosing spondylitis and the commencement of anti-TNF therapy in daily rheumatology practice. Ann Rheum Dis. 2007 Aug;66(8):1072-7. doi: 10.1136/ard.2006.064543

6. Фоломеева ОМ. К проблеме определения внесуставных проявлений ревматоидного артрита. Научно-практическая ревматология. 2008;46(2):74-82 [Folomeeva OM. About the problem of rheumatoid arthritis extra-articular features determination. Nauchno-Prakticheskaya Revmatologiya = Rheumatology Science and Practice. 2008;46(2):74-82 (In Russ.)]. doi: 10.14412/1995-4484-2008-436

7. Momeni M, Taylor N, Tehrani M. Cardiopulmonary manifestations of ankylosing spondylitis.International J Rheumatol. 2011;2011:Article ID 728471, 6 p. doi: 10.1155/2011/728471

8. Rodrigues C, Vieira W, Bortoluzzo A, et al. Low prevalence of renal, cardiac, pulmonary, and neurological extra-articular clinical manifestations in spondyloarthritis: analysis of the Brazilian Registry of Spondyloarthritis. Rev Bras Reumatol (Sao Paulo). 2012 May/June;52(3). doi: 10.1590/s0482-50042012000300008

9. El Maghraoui A. Extra-articular manifestations of ankylosing spondylitis: Prevalence, characteristics and therapeutic implications. Eur J Intern Med. 2011 Dec;22(6):554-60. doi: 10.1016/j.ejim.2011.06.006

10. Zarco P, Gonzalez C, Rodriguez de la Serna A, et al. Extra-articular disease in patients with spondyloarthritis. Baseline characteristics of the spondyloarthritis cohort of the AQUILES study. Reumatol Clin. 2015 Mar-Apr;11(2):83-9. doi: 10.1016/j.reuma.2014.04.003

11. 2003-2016 ASAS-group.org v2.4. Slide-educational kit.

12. Bergfeldt L. HLA-B27-associated Cardiac Disease. Ann Intern Med. 1997 Oct 15;127(8 Pt 1):621-9. doi: 10.7326/0003-4819-127- 8_Part_1-199710150-00007

13. Laitinen O, Leirisalo M, Skylv G. Relation between HLA-B27 and clinical features in patients with Yersinia arthritis. Arthritis Rheum. 1977;20:1121-4. doi: 10.1002/art.1780200512

14. Годзенко АА, Бочкова АГ, Корсакова ЮО и др. Поражение сердца при анкилозирующем спондилите. Научно- практическая ревматология. 2009;47(4):4-10 [Godzenko AA, Bochkova AG, Korsakova YuO, et al. Heart damage in ankylosing spondylitis. Nauchno-Prakticheskaya Revmatologiya = Rheumatology Science and Practice. 2009;47(4):4-10 (In Russ.)]. doi: 10.14412/1995-4484-2009-1144

15. Montenegro V, Monteiro R. Elevation of serum IgA in spondyloarthropathies and IgA nephropathy and its pathogenic role. Curr Opin Rheum. 1999;11:265-72. doi: 10.1097/00002281-199907000- 00007

16. Forshaw M, Guirguis O, Hennigan T. IgA nephropathy in association with Crohn disease. Int J Colorectal Dis. 2005 Sep;20(5):463-5. doi: 10.1007/s00384-004-0696-z

17. Lai KN, Leung JCK, Chan LYY, et al. Activation of podocytes by mesangial-derived TNF-α: glomerulo-podocytic communication in IgA nephropathy. Am J Physiol Renal Physiol. 2008 Apr;294(4):F945-55. doi: 10.1152/ajprenal.00423.2007. Epub 2008 Feb 6.

18. Matsuki T, Isoda K, Horai R, et al. Involvement of tumor necrosis factor-α in the development of T cell-dependent aortitis in interleukin-1 receptor antagonist-deficient mice. Circulation. 2005;112:1323-31. doi: 10.1161/CIRCULATIONAHA.105.564658

19. Эрдес ШФ, Бочкова АГ, Дубинина ТВ и др. Проект рабочей классификации анкилозирующего спондилита. Научно- практическая ревматология. 2013;51(6):604-8 [Erdes SF, Bochkova AG, Dubinina TV, et al. Project of working classification of ankylosing spondilytis. Nauchno-Prakticheskaya Revmatologiya = Rheumatology Science and Practice. 2013;51(6):604-8 (In Russ.)]. doi: 10.14412/1995-4484-2013-604-8

20. Essers I, Ramiro S, Stolwijk C, et al. Characteristics associated with the presence and development of extra-articular manifestations in ankylosing spondylitis: 12-year results from OASIS. Rheumatology (Oxford). 2015 Apr;54(4):633-40. doi: 10.1093/rheumatology/keu388. Epub 2014 Sep 17.

21. Essers I, Ramiro S, Stolwijk C, et al. Do extra-articular manifestations influence outcome in ankylosing spondylitis? 12-year results from OASIS Clin Exp Rheumatol. 2016 Feb 2. [Epub ahead of print].

22. Stolwijk C, van Tubergen A, Castillo-Ortiz JD, Boonen A. Prevalence of extra-articular manifestations in patients with ankylosing spondylitis: a systematic review and meta-analysis. Ann Rheum Dis. 2013 Sep 2. doi: 10.1136/annrheumdis-2013-203582 [Epub ahead of print].

23. Garcia-Vicu R, Zarco P, Vanaclocha G, et al. Two-year incidence of psoriasis, uveitis and inflammatory bowel disease in patients with spondyloarthritis: A Study in the AQUILES Cohort. Reumatol Clin. 2016;12(1):22-6.

24. Yang P, Wang H, Zhang Z, et al. Clinical diagnosis and treatment of uveitis associated with ankylosing spondylitis. Zhonghua Yan KeZaZhi. 2005 Jun;41(6):515-8.

25. Gouveia E, Elmann D, Morales M. Ankylosing spondylitis and uveitis: overview. Rev Bras Reumatol (Sao Paulo). 2012 Sept/Oct;52(5). doi: 10.1590/S0482-50042012000500009

26. Brunner F, Kunz A, Weber U, Kissling R. Ankylosing spondylitis and heart abnormalities: do cardiac conduction disorders, valve regurgitation and diastolic dysfunction occur more often in male patients with diagnosed ankylosing spondylitis for over 15 years than in the normal population. Clin Rheumatol. 2006 Feb;25(1):24- 9. doi: 10.1007/s10067-005-1117-6. Epub 2005 Oct 25.

27. Lautermann D, Braun J. Ankylosing spondylitis – cardiac manifestations. Clin Exp Rheumatol. 2002;20(6 Suppl 28):511-15.

28. Klingberg E, Sveä lv B, Tä ng M, et al. Aortic regurgitation is common in ankylosing spondylitis: Time for routine echocardiography evaluation? Am J Med. 2015 Nov;128(11):1244-50. doi: 10.1016/j.amjmed.2015.04.032. Epub 2015 Jun 4.

29. Heslinga SC, et al. High Prevalence of Cardiac Disease in Patients with Ankylosing Spondylitis 2015 ACRARHR Annual Meeting. September 29, 2015.

30. Van der Linden S, Valkenburg H, Cats A. Evaluation of diagnostic criteria for ankylosing spondylitis: a proposal to modification of the New York criteria. Arthr Rheum. 1984;27:361-8. doi: 10.1002/art.1780270401

31. Fredriksson T, Pettersson U. Severe psoriasis – oral therapy with a new retinoid. Dermatologica. 1978;157:238-44. doi: 10.1159/000250839

32. K/DOQI Clinical Practice Guidelines for Chronic Kidney Disease: Evaluation, Classification, and Stratification. Am J Kidney Dis. 2002;39:2.

33. Harvey R, Bradshaw J. A simple index of Crohn's disease activity. Lancet. 1980;315(8167):514. doi: 10.1016/S0140-6736(80)92767-1

34. Abel G, Terry J. Ankylosing spondylitis and recurrent anterior uveitis. Am Optom Assoc. 1991;62:844-8.

35. Годзенко АА, Бочкова АГ, Румянцева ОА и др. Течение и исходы увеита у больных анкилозирующим спондилитом. Научно-практическая ревматология. 2014;52(5):520-5 [Godzenko AA, Bochkova AG, Rumyantseva OA, et al. Progression and outcomes of uveitis in patients with ankylosing spondilitis. Nauchno-Prakticheskaya Revmatologiya = Rheumatology Science and Practice. 2014;52(5):520-5 (In Russ.)]. doi: 10.14412/1995-4484-2014-520-525

36. Levy-Clarke G, Jabs DA, Read RW, et al. Expert panel recommendations for the use of anti-tumor necrosis factor biologic agents in patients with ocular inflammatory disorders. Ophthalmology. 2014 Mar;121(3):785-96.e3. doi: 10.1016/j.ophtha.2013.09.048. Epub 2013 Dec 17.

37. Федеральные клинические рекомендации по диагностике и лечению анкилозирующего спондилита, 2013 г. с поправкой 2016 г. [Federal'nye klinicheskie rekomendatsii po diagnostike i lecheniyu ankiloziruyushchego spondilita, 2013 g. s popravkoi 2016 g. [Federal clinical guidelines for the diagnosis and treatment of ankylosing spondylitis, 2013, amended 2016]].

38. Годзенко АА, Бочкова АГ, Румянцева ОА и др. Влияние терапии ингибиторами фактора некроза опухоли α на частоту обострений увеита у больных анкилозирующим спондилитом. Научно-практическая ревматология. 2014;52(1):27-30 [Godzenko AA, Bochkova AG, Rumyantseva OA, et al. Impact of the therapy with tumor necrosis factor α inhibitors on the frequency of uveitis exacerbations in patients with ankylosing spondylitis. Nauchno-Prakticheskaya Revmatologiya = Rheumatology Science and Practice. 2014;52(1):27-30 (In Russ.)]. doi: 10.14412/1995-4484-2014-27-30

39. Park So-Hee, Sohn Il-Suk, Joe Byung-Hyun, et al. Early cardiac valvular changes in ankylosing spondylitis: A transesophageal echocardiography study J Cardiovasc Ultrasound. 2012 Mar;20(1):30-36. doi: 10.4250/jcu.2012.20.1.30

40. Godzenko A, Korsakova Y, Bochkova A, et al. Progression of aortic and valve abnormalities in patients with ankylosing spondylitis. Annual European Congress of Rheumatology EULAR; 2016, Abstracts. AB0666.

41. Трушина ЛС. Разработка дифференциально-диагностических критериев псориатического и ревматоидного артритов. Дисс. … канд. мед. наук. Москва; 1983. С. 58-61 [Trushina LS. Razrabotka differentsial'no-diagnosticheskikh kriteriev psoriaticheskogo i revmatoidnogo artritov. Diss. … kand. med. nauk [Development of differential diagnostic criteria for psoriatic and rheumatoid arthritis. Diss. ... Cand. Med. Sci.]. Moscow; 1983. P. 58-61].

42. Молочков ВА, Бадокин ВВ, Альбанова ВИ, Волнухин ВА. Псориаз и псориатический артрит. Москва; 2007 [Molochkov VA, Badokin VV, Al'banova VI, Volnukhin VA. Psoriaz i psoriaticheskii artrit [Psoriasis and psoriatic arthritis]. Moscow; 2007].

43. Taylor W, Gladman D, Helliwell P, et al; CASPAR Study Group. Classification criteria for psoriatic arthritis: development of new criteria from a large international study. Arthritis Rheum 2006;54:2665-73. doi: 10.1002/art.21972

44. Vavricka S, Brun L, Ballabeni P, et al. Frequency and risk factors for extraintestinal manifestations in the Swiss inflammatory bowel disease cohort. Am J Gastroenterol. 2011 Jan;106(1):110-9. doi: 10.1038/ajg.2010.343. Epub 2010 Aug 31.

45. De Vlam K, Mielants H, Cuvelier C, et al. Spondylarthropathy is underestimated in inflammatory bowel disease: prevalence and HLA association. J Rheumatol. 2000 Dec;27(12):2860-5.

46. Кузин АВ. Поражение суставов и позвоночника у больных воспалительными заболеваниями кишечника: Автореф. дисс. … канд. мед. наук. Москва; 2016 [Kuzin AV. Porazhenie sustavov i pozvonochnika u bol'nykh vospalitel'nymi zabolevaniyami kishechnika. Avtoref. diss. … kand. med. nauk [The defeat of the joints and spine in patients with inflammatory bowel diseases. Author's abstract. Diss. ... Cand. Med. Sci.]. Moscow; 2016].

47. Годзенко АА, Бочкова АГ, Румянцева ОА и др. Взаимосвязь между поражением сердца и другими клиническими проявлениями анкилозирующего спондилита. Научно- практическая ревматология. 2010;48(5):32-6 [Godzenko AA, Bochkova AG, Rumyantseva OA, et al. Association between cardiac lesion and other clinical manifestationsof ankylosing spondylitis. Nauchno-Prakticheskaya Revmatologiya = Rheumatology Science and Practice. 2010;48(5):32-6 (In Russ.)]. doi: 10.14412/1995-4484-2010-728